H.R. 8630In Committee
To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
Key facts
Introduced: Apr 30, 2026
Chamber: House
Cosponsors: 1
Congress: 119th
Latest action · Apr 30, 2026
Referred to the House Committee on Energy and Commerce.
Timeline
- Apr 30, 2026Referred to the House Committee on Energy and Commerce.
- Apr 30, 2026Introduced in House
- Apr 30, 2026Introduced in House
Cosponsors
View official record on Congress.gov →